Pharmacist Digest

AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData

Express Pharma

APRIL 25, 2024

Since then, the PARP inhibitors market has made significant strides, but Lynparza maintains its dominance with projected global sales of $4 billion by 2027, according to an analyst consensus forecast by GlobalData. Expected revenues in these indications will reach over 68 per cent of the global PARP inhibitors market by 2027.

Chemotherapy

India pharma tech’s next big opportunity lies in sales and marketing stack: Bessemer Venture Partners

Express Pharma

DECEMBER 11, 2023

Bessemer Venture Partners, a leading global venture capital and private equity firm released its report focused on the sales and marketing stack of Indian pharma companies, analysing India’s burgeoning pharma market and the role of technology in further amplifying this growth.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Santosh Singh, GM – Sales & Marketing, Romaco India | PPL Conclave 2024

Express Pharma

MARCH 20, 2024

In this video: Santosh Singh, GM – Sales & Marketing, Romaco India Key Takeaway: Romaco Noack Unity 600 is the machine housing made of 100 per cent recycled plexiglass and reduces 76 per cent carbon emission The post Santosh Singh, GM – Sales & Marketing, Romaco India | PPL Conclave 2024 appeared first on Express Pharma.

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

DECEMBER 23, 2022

Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes.

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData

Express Pharma

APRIL 18, 2023

The market for multiple sclerosis (MS) disease-modifying therapies (DMT) is set to experience moderate growth across the seven major markets (7MM*) from $18.9 The superior efficacy and safety profiles of these therapies are expected to improve treatment rates and drive an increase in market size. billion in 2020 to $29.8

Compounding

Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData

Express Pharma

NOVEMBER 8, 2023

The market for myasthenia gravis (MG), an autoimmune and neuromuscular disease characterised by muscle weakness and fatigue, is set to experience a compound annual growth rate (CARG) of 8.3 per cent across the seven major markets (7MM*) from $3 billion in 2022 to $6.7 The post Myasthenia gravis market to generate sales of $6.7

Labelling

Labelling Compounding

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

Pharma Marketing Network

APRIL 21, 2021

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences.

AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029: GlobalData

Express Pharma

OCTOBER 10, 2023

Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio, with anticipated sales surpassing $7 billion and a 48 per cent market share of small molecules in lung cancer treatment by 2029, according to GlobalData. Roche is expected to secure the second position with projected sales of over $2.5

Current State of the Pharma Sales and Marketing Sales Force

PharmExec

APRIL 22, 2024

Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

Pharmaceutical Technology

MAY 2, 2024

Novo Nordisk noted a 22% boost in sales owing to increased sales of GLP-1 agonists and other obesity products.

Talent Management Strategies for Sales and Marketing

PharmExec

DECEMBER 22, 2022

Angie Lindsey, vice president of marketing, Fresenius Kabi USA shares 2023 strategies for talent management strategies in life sciences, specifically as it relates to sales and marketing.

The transition from Pharma Sales to Pharma Marketing | Humans of Pharma

PharmaState Academy

APRIL 4, 2023

This is the first career discussion interview with our guest speaker, Zena D’souza about the topic, “The Transition from Pharma Sales to Pharma Marketing” Zena D’souza has 25 years of experience in the pharmaceutical industry, working in various departments and companies.

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

MAY 19, 2021

Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. With more than 18.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

How Can Marketing Support The Sales Team’s Success?

PharmaKinnex

MAY 15, 2022

How Can Marketing Support The Sales Team’s Success? A pharmaceutical company’s sales force is an ongoing, expensive investment that can cost as much as tens to hundreds of millions of dollars annually. Sales managers are under pressure to meet sales targets while also onboarding, training, and mobilizing new sales reps.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Physician Offices Hospitals

In Flux: The Sales & Marketing Outlook for 2023

PharmExec

DECEMBER 22, 2022

Pratap Khedkar, CEO of ZS, a management consulting and technology firm focused on transforming global healthcare, shares his perspective on what 2023 holds for the sales and marketing vertical.

Artificial Intelligence (AI) in Pharma Sales and Marketing

Pharma Mirror

OCTOBER 17, 2022

The post Artificial Intelligence (AI) in Pharma Sales and Marketing appeared first on Pharma Mirror Magazine. This could be used to determine target audiences, decide on optimal times to send emails, or segment out groupings for deeper engagement. Deep learning In.

3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales

PharmaKinnex

APRIL 28, 2022

3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales April 28, 2022. The above factors can yield higher sales, making rare disease drug development extremely lucrative and desirable. The power of inside sales begins here. Market Research & Territory Alignment.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development

STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case

STAT

MAY 7, 2024

billion in criminal penalties and another $450 million in criminal forfeiture for illegally marketing its Opana ER prescription opioid. In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Vaibhav Datke, Sr Manager – Business Development, Ami Polymer & Radhakrishna A, Sr Manager – Sales & Marketing, Ami Polymer

Express Pharma

JUNE 29, 2023

In this video: Vaibhav Datke, Sr Manager – Business Development, Ami Polymer & Radhakrishna A, Sr Manager – Sales & Marketing, Ami Polymer Topic: Polymer Solutions For Pharma Industry Key Takeaway: Ami Polymer, apart from offering a wide range of new age polymeric solutions, also provides quick customisation, technical documentation (..)

Documentation

Prabhat Balyan, Asst. Manager – Business Development, Ami Polymer & Dhruv Borda, Asst. Manager – Sales & Marketing, Ami Polymer

Express Pharma

JUNE 16, 2023

Manager – Sales & Marketing, Ami Polymer Topic: Polymeric solutions for pharma, biopharma and medical industry Key Takeaway: Ami Polymer offers a wide range of tubings and hoses which are used advantageously to improve pharma processes. Manager – Sales & Marketing, Ami Polymer appeared first on Express Pharma.

STAT+: Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion

STAT

APRIL 29, 2024

Deciphera markets a drug called Qinlock for patients with advanced gastrointestinal stromal tumors, or GIST, a type of cancer that begins in the digestive system. Sales last year were $160 million. The all-cash deal values Diciphera at $25.60 per share, or a 75% premium to its Friday closing stock price.

STAT+: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline

STAT

MAY 10, 2024

market until July 2022 , long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

Vaccines

Lilly market value soars on higher sales, obesity drug potential

BioPharma Dive

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

How Market Listening Can Help Drive Your Pharma Sales Funnel

Pharma Mirror

APRIL 14, 2021

The role of pharma sales reps is an incredibly important part of this lifecycle from initial research to point of sale and distribution, with reps connecting the groundbreaking research and technology of pharma companies with healthcare professionals and medical establishments.

Entry deadline extended for the 2021 Marketer of the Year, Sales and Communications Awards!

Pharma Times

SEPTEMBER 10, 2021

The entry deadline for the 2021 Marketer of the Year, Sales and Communications Awards has been extended to 22nd of October

Communication

STAT+: Akili to lay off 46% of its staff, explore strategic options amid sluggish sales

STAT

APRIL 30, 2024

Akili Interactive on Tuesday announced it will lay off 46% of its staff and evaluate strategic alternatives amid sluggish sales of its prescription video game treatment for attention deficit hyperactivity disorder. Last year, Akili announced it would shift the whole business to marketing non-prescription treatments directly to consumers.

Diabetes

Zee Laboratories Ltd-Openings for QC-Micro/QA/ IPQA/ F&D/ DRA/ PMT/ Sales/ Admin/ Digital Marketing/ IT Networking/ Personnel Assistant/ Telecalling / HR-Apply Now

Pharma Pathway

FEBRUARY 28, 2023

Zee Laboratories Ltd-Openings for QC- Micro/QA/ IPQA/ F&D/ DRA/ PMT/ Sales/ Admin/ Digital Marketing/ IT Networking/ Personnel Assistant/ Telecalling / HR-Apply Now Job Description Openings for QC-Micro/QA/ IPQA/ F&D/ DRA/ PMT/ Sales/ Admin/ Digital Marketing/ IT Networking/ Personnel Assistant/ Telecalling / HR @ Zee Laboratories Ltd Departments: (..)

Indegene Launches Invisage, a New Omnichannel Sales and Marketing Platform

PharmExec

AUGUST 23, 2023

Program designed to aid life science organizations in improving go-to-market strategy.

STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market

STAT

APRIL 4, 2024

WASHINGTON — Boehringer Ingelheim is laying off or relocating its sales staff for its Humira biosimilar Cyltezo in a sign of how difficult it’s been to get drug middlemen to adopt less-expensive versions of the blockbuster, the company confirmed. After two decades on the U.S.

Biosimilars

Biosimilars Drug Pricing

STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

STAT

MARCH 8, 2024

But the case of Relyvrio, which made $381 million in sales and $49 million in profit for Amylyx last year, has underlined questions about the limits of regulatory leniency. After years of pressure from patient advocates, the agency has taken a more flexible approach to medicines for devastating, incurable diseases like ALS.

Drug Development

STAT+: Alnylam reports growth in sales of rare disease treatments

STAT

AUGUST 3, 2023

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September. The FDA has scheduled a meeting of outside experts on Sept. The FDA decision is due by Oct.

STAT+: Bernie Sanders targets ‘outrageously high price’ of Ozempic

STAT

APRIL 25, 2024

The need-to-know this morning AstraZeneca reported first-quarter sales and profits that topped analyst estimates, buoyed by its blockbuster cancer drugs. It’s a busy day for pharma earnings: Merck , Sanofi , Daiichi Sankyo , Astellas , and Bristol Myers Squibb.

Hospitals

Hospitals Drug Pricing

STAT+: European Parliament votes in favor of updated pharma legislation, prompting mixed reactions

STAT

APRIL 11, 2024

The European Parliament has voted overwhelmingly to adopt legislation that is supposed to transform the way medicines are brought to market and accessed across much of Europe. But the effort — which must still be approved by the European Council — drew mixed reactions from the pharmaceutical industry and consumer groups.

Spectral AI nears first sales of wound care system

pharmaphorum

MAY 8, 2024

The first commercial sales of Spectral AI's DeepView wound imaging system for burns are due to start in the UK, its first market, later this year

STAT+: Electronic health record maker NextGen Healthcare to pay $31 million to resolve fraud claims

STAT

JULY 17, 2023

The settlement caps a lengthy investigation that cast a harsh light on NextGen’s efforts to gain market share in the sharp-elbowed business of selling electronic health records software. The government said the company also gave tickets to sporting events and other entertainment to induce referrals and sales.

Hospitals

Pharma Industry Townhall to be held in Mumbai

Express Pharma

MARCH 11, 2024

The niche of this event extends to every pharma company present in India, thus this Townhall presents an open knowledge-sharing platform for sales and marketing professionals. Attendees will gain knowledge, actionable insights, and a renewed perspective on the evolving realm of pharma sales and marketing.

Medical Records

Medical Records Communication

STAT+: Why Eli Lilly’s earnings didn’t quite live up to the hype

STAT

FEBRUARY 6, 2024

It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion. At first, the earnings report suggested the company had blasted through expectations again, announcing fourth quarter 2023 sales of $9.35

Diabetes

STAT+: Apple Watch pulse oximeter feature removed to comply with ban

STAT

JANUARY 18, 2024

But the court lifted that injunction on Wednesday, forcing Apple to again halt sales. Rather than pull the watches from the market, Apple decided to remove the blood oxygen feature instead. The ban officially went into effect on Christmas , but a U.S. appeals court temporarily halted the ban two days later.

Indegene Launches Invisage, a New Omnichannel Sales and Marketing Platform

Pharmaceutical Commerce

AUGUST 24, 2023

Program designed to aid life science organizations in improving go-to-market strategy.

Bayer secures full ownership of Bayer Zydus Pharma, acquires remaining 25 per cent stakes

Express Pharma

MAY 2, 2024

The 50:50 joint venture was established on January 28, 2011, for the sales and marketing of pharmaceutical products in India. A press statement from Bayer informed, “The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market.

Diabetes

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

Pharmafile

FEBRUARY 10, 2023

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug Humira, as new competition emerges in the form of cheaper biosimilar drugs. The company expects its sales to stabilise by the end of 2024. read more

Biosimilars

STAT+: 8 burning questions Bernie Sanders and other senators should ask Moderna’s Stéphane Bancel

STAT

MARCH 21, 2023

Bernie Sanders’ health committee on Wednesday, where he’ll have to defend his company’s suggestion it will likely quadruple the price of its Covid vaccines once sales transition from bulk federal purchases to the open market. Continue to STAT+ to read the full story…

Vaccines

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

Express Pharma

MARCH 15, 2024

The ascent of GLP1 agonists is anticipated to surpass PD1 antagonists as the leading drugs on the market in 2024, says GlobalData. Kevin Marcaida, Pharma Analyst at GlobalData, comments, “PD1 antagonists dominated the market, reigning as the best-selling drugs by mechanism of action with $38.9 billion in sales.

Diabetes

Diabetes Compounding

AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData

India pharma tech’s next big opportunity lies in sales and marketing stack: Bessemer Venture Partners

Trending Sources

Santosh Singh, GM – Sales & Marketing, Romaco India | PPL Conclave 2024

7 commercial, sales, and marketing predictions for 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData

Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029: GlobalData

Current State of the Pharma Sales and Marketing Sales Force

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

Talent Management Strategies for Sales and Marketing

The transition from Pharma Sales to Pharma Marketing | Humans of Pharma

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

How Can Marketing Support The Sales Team’s Success?

In Flux: The Sales & Marketing Outlook for 2023

Artificial Intelligence (AI) in Pharma Sales and Marketing

3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales

STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case

Vaibhav Datke, Sr Manager – Business Development, Ami Polymer & Radhakrishna A, Sr Manager – Sales & Marketing, Ami Polymer

Prabhat Balyan, Asst. Manager – Business Development, Ami Polymer & Dhruv Borda, Asst. Manager – Sales & Marketing, Ami Polymer

STAT+: Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion

STAT+: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline

Lilly market value soars on higher sales, obesity drug potential

How Market Listening Can Help Drive Your Pharma Sales Funnel

Entry deadline extended for the 2021 Marketer of the Year, Sales and Communications Awards!

STAT+: Akili to lay off 46% of its staff, explore strategic options amid sluggish sales

Zee Laboratories Ltd-Openings for QC-Micro/QA/ IPQA/ F&D/ DRA/ PMT/ Sales/ Admin/ Digital Marketing/ IT Networking/ Personnel Assistant/ Telecalling / HR-Apply Now

Indegene Launches Invisage, a New Omnichannel Sales and Marketing Platform

STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market

STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

STAT+: Alnylam reports growth in sales of rare disease treatments

STAT+: Bernie Sanders targets ‘outrageously high price’ of Ozempic

STAT+: European Parliament votes in favor of updated pharma legislation, prompting mixed reactions

Spectral AI nears first sales of wound care system

STAT+: Electronic health record maker NextGen Healthcare to pay $31 million to resolve fraud claims

Pharma Industry Townhall to be held in Mumbai

STAT+: Why Eli Lilly’s earnings didn’t quite live up to the hype

STAT+: Apple Watch pulse oximeter feature removed to comply with ban

Indegene Launches Invisage, a New Omnichannel Sales and Marketing Platform

Bayer secures full ownership of Bayer Zydus Pharma, acquires remaining 25 per cent stakes

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

STAT+: 8 burning questions Bernie Sanders and other senators should ask Moderna’s Stéphane Bancel

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

Stay Connected